World's First iPS Cell-Based Heart Therapy Performed in Osaka
- Published:
- First detected:
Insights by Echo AI
A groundbreaking medical procedure took place in Osaka, Japan, where a heart muscle sheet created from induced pluripotent stem (iPS) cells was successfully transplanted into a heart failure patient. This marks the first time such a therapy has been used in a clinical setting and is covered by insurance. The surgery was performed at Osaka Police Hospital and involved a product called RiHEART, developed by Cuorips Inc. The patient's condition is stable, and they may be discharged within two weeks if recovery proceeds smoothly.
Source coverage
13
records merged
10
10 unique
0
0 unique
3
3 unique
13 Sources
iPS細胞で作った心筋シート、世界初の実用化 心不全患者に移植
iPS細胞で作った心筋シート、世界初の実用化 心不全患者に移植 https://t.co/AKITy0tTHk iPS細胞からつくった心...
【iPS細胞の心筋シート 初の実用化】 https://t.co/0TrUQLydsM
1st iPS Regenerative Medicine Product Transplanted in Japan (Adnkronos...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
